GE HealthCare Technologies (NASDAQ:GEHC) Price Target Increased to $102.00 by Analysts at Evercore ISI

GE HealthCare Technologies (NASDAQ:GEHC) had its price target boosted by equities research analysts at Evercore ISI from $98.00 to $102.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Evercore ISI’s price target suggests a potential upside of 12.04% from the company’s previous close.

Several other analysts have also recently issued reports on the stock. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. Stifel Nicolaus lifted their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a research report on Monday. BTIG Research raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research note on Wednesday, September 18th. JPMorgan Chase & Co. assumed coverage on GE HealthCare Technologies in a research note on Monday, September 9th. They issued a “neutral” rating and a $90.00 target price for the company. Finally, UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and reduced their target price for the stock from $84.00 to $74.00 in a research note on Thursday, September 26th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, GE HealthCare Technologies has an average rating of “Moderate Buy” and a consensus target price of $94.23.

GE HealthCare Technologies Price Performance

Shares of GE HealthCare Technologies stock opened at $91.04 on Tuesday. The stock has a market capitalization of $41.56 billion, a P/E ratio of 26.62, a PEG ratio of 3.40 and a beta of 1.17. The business has a 50 day simple moving average of $85.83 and a two-hundred day simple moving average of $83.33. GE HealthCare Technologies has a 12 month low of $62.35 and a 12 month high of $94.55. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.06 and a quick ratio of 0.82.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, beating the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The firm had revenue of $4.84 billion during the quarter, compared to the consensus estimate of $4.88 billion. During the same period in the prior year, the company earned $0.92 EPS. The firm’s revenue was up .5% compared to the same quarter last year. As a group, analysts predict that GE HealthCare Technologies will post 4.26 EPS for the current fiscal year.

Insider Transactions at GE HealthCare Technologies

In related news, CEO Thomas J. Westrick sold 2,750 shares of the firm’s stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total value of $222,145.00. Following the sale, the chief executive officer now owns 17,509 shares of the company’s stock, valued at $1,414,377.02. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.27% of the company’s stock.

Institutional Investors Weigh In On GE HealthCare Technologies

Large investors have recently modified their holdings of the company. Global Assets Advisory LLC acquired a new position in shares of GE HealthCare Technologies during the first quarter worth $4,273,000. Vanguard Group Inc. lifted its holdings in GE HealthCare Technologies by 9.2% during the 1st quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock worth $4,410,893,000 after buying an additional 4,107,746 shares during the last quarter. Mather Group LLC. acquired a new position in shares of GE HealthCare Technologies during the 1st quarter worth about $106,000. Bank of Montreal Can increased its holdings in shares of GE HealthCare Technologies by 27.5% in the 2nd quarter. Bank of Montreal Can now owns 696,446 shares of the company’s stock valued at $54,964,000 after acquiring an additional 150,137 shares during the last quarter. Finally, Sei Investments Co. raised its position in shares of GE HealthCare Technologies by 30.6% during the 1st quarter. Sei Investments Co. now owns 279,336 shares of the company’s stock worth $25,393,000 after acquiring an additional 65,476 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.